Association between the TP53 and CYP2E1*5B gene polymorphisms and non-small cell lung cancer
, , , , , , et | 22 déc. 2016
À propos de cet article
Publié en ligne: 22 déc. 2016
Pages: 311 - 316
Reçu: 01 avr. 2016
Accepté: 01 déc. 2016
DOI: https://doi.org/10.1515/aiht-2016-67-2812
Mots clés
© Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Ahmet Oguz Ada
Department of Toxicology, Faculty of Pharmacy, University of Ankara, 06100 Tandoğan, Ankara, Turkey
Serdar Bilgen
Department of Toxicology, Faculty of Pharmacy, University of Ankara, Ankara, Turkey
Volkan Karacaoglan
Department of Toxicology, Faculty of Pharmacy, University of Ankara, Ankara, Turkey
Celalettin Semih Kunak
Department of Toxicology, Faculty of Pharmacy, University of Ankara, Ankara, Turkey
Emre Soydas
Department of Toxicology, Faculty of Pharmacy, University of Ankara, Ankara, Turkey
Sibel Alpar
Ataturk Pulmonary Diseases and Thoracic Surgery Hospital, Ankara, Turkey
Meral Gulhan
Ataturk Pulmonary Diseases and Thoracic Surgery Hospital, Ankara, Turkey
Mumtaz Iscan
Department of Toxicology, Faculty of Pharmacy, University of Ankara, Ankara, Turkey